Nyxoah SA (EBR:NYXH)
Belgium · Delayed Price · Currency is EUR 6.46
-0.04 (-0.62%)
At close: Aug 8, 2025, 5:30 PM CET
Nyxoah Market Cap
Nyxoah has a market cap or net worth of €241.83 million as of August 8, 2025. Its market cap has decreased by -9.80% in one year.
Market Cap
241.83M
Enterprise Value
200.88M
Revenue
4.36M
Ranking
n/a
PE Ratio
n/a
Stock Price
€6.46
Market Cap Chart
Since September 18, 2020, Nyxoah's market cap has decreased from 417.77M to 241.83M, a decrease of -42.11%. That is a compound annual growth rate of -10.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 8, 2025 | 241.83M | -21.77% |
| Dec 31, 2024 | 309.15M | 153.09% |
| Dec 29, 2023 | 122.15M | -8.05% |
| Dec 30, 2022 | 132.85M | -72.29% |
| Dec 31, 2021 | 479.37M | 37.44% |
| Dec 31, 2020 | 348.77M | -16.52% |
| Sep 18, 2020 | 417.77M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| argenx SE | 35.24B |
| UCB SA | 35.05B |
| Financière de Tubize | 6.69B |
| Fagron NV | 1.51B |
| Ion Beam Applications | 330.71M |
| Onward Medical | 189.07M |
| Hyloris Pharmaceuticals | 179.76M |
| Sequana Medical NV | 79.37M |